摘要:
A child car seat comprises a seat body including a seat wall and a backrest wall, and a V-shaped shield structure extending from above both shoulders to a crotch of a child. The V-shaped shield structure includes a belt extending in the shape of the letter V, a belt guiding member guiding the belt and an elastic cover surrounding the belt guiding member.
摘要:
A juvenile safety car seat has a seat portion and a backrest portion forming a support and defining a support space for supporting a child. A pair of side guards are outwardly movably provided on left and right sides of the backrest portion for protecting the head and the shoulder regions of the child. The lower portions of the side guards, which protect the child's shoulders, have a greater range of outward lateral movement than the upper portions of the side guards, which protect the child's head. A vertical position adjusting mechanism for adjusting the vertical position of the backrest portion is provided between the seat portion and the backrest portion. The car seat can be selectively adjusted to suit the growth state of the child.
摘要:
A vehicular child safety seat comprises a waist belt engaging portion for deciding the vertical position of a waist belt provided on a movable member displaceable with respect to a base portion and locking means for restricting displacement of the movable member with respect to the base portion. The movable member is rendered rotatable about an axis X—X. A user can adjust the vertical position of the waist belt by rotating the movable member. The user can further fix the vertical position by changing the direction of a switch portion.
摘要:
Disclosed herein is a baby table chair which is usable as a shoulder harness for carrying a baby. The table chair comprises a chair portion for seating the baby thereon, an arm portion for supporting the chair portion, a pair of shoulder belts which are mounted between the chair portion and the arm portion, and an arm mounting portion for rotatably supporting the arm portion. The arm mounting portion positions and fixes the arm portion in front of the chair portion for holding a table with the arm portion thereby using the table chair as such, and under the chair portion for using the table chair as a shoulder harness.
摘要:
Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient. A sensitizing detection agent for bladder cancer comprising 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these is orally or intravenously administered, and a video camera system is inserted via the urethra and a blue light at 380-440 nm is irradiated to observe the red fluorescent part. Further, VLD-M1 is inserted and a blue light at 405 nm is irradiated to observe fluorescence intensity (relative intensity) of the red light part. For oral administration, 20 mg/kg (maximum of 1 g) of ALA is dissolved in 50 mL of a 5% glucose solution prior to the administration.
摘要:
Workpieces, which are conveyed by a conveying device along a conveying path, are heated by a heating and degreasing coil. Then, resin powder is downwardly sprayed from a nozzle of a coating device to each corresponding one of the workpieces, which are conveyed by the conveying device. The workpieces are thereafter heated by a heating and curing coil. At each of the heating coils, a dummy member, which is made of an electrically conductive material, is displaced from a retracted position to a forward position, which is located between the corresponding heating coil and a corresponding adjacent part of the conveying path of the conveying device, when an empty one of mount locations of the conveying device reaches the forward position of the dummy member.
摘要:
Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient. A sensitizing detection agent for bladder cancer comprising 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these is orally or intravenously administered, and a video camera system is inserted via the urethra and a blue light at 380-440 nm is irradiated to observe the red fluorescent part. Further, VLD-M1 is inserted and a blue light at 405 nm is irradiated to observe fluorescence intensity (relative intensity) of the red light part. For oral administration, 20 mg/kg (maximum of 1 g) of ALA is dissolved in 50 mL of a 5% glucose solution prior to the administration.